| RMEBX | RSOOX | RMEBX / RSOOX | |
| Total Expense Ratio | 1.07 | 1.28 | 84% |
| Annual Report Gross Expense Ratio | 1.07 | 1.28 | 84% |
| Fund Existence | 12 years | 18 years | - |
| Gain YTD | 7.309 | 16.246 | 45% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 117B | 2.61B | 4,483% |
| Annual Yield % from dividends | 0.99 | 1.89 | 52% |
| Returns for 1 year | 3.55 | 14.11 | 25% |
| Returns for 3 years | 33.39 | 43.61 | 77% |
| Returns for 5 years | 33.68 | 32.87 | 102% |
| Returns for 10 years | 89.90 | 51.90 | 173% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FBOT | 38.03 | -0.06 | -0.15% |
| Fidelity Disruptive Automation ETF (FBOT) | |||
| VBCC | 74.36 | -0.15 | -0.20% |
| Vanguard Target Maturity 2029 Corporate Bond ETF (VBCC) | |||
| CDC | 74.05 | -0.57 | -0.76% |
| VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) | |||
| XBI | 156.72 | -1.53 | -0.97% |
| State Street SPDR S&P Biotech ETF (XBI) | |||
| AMZD | 8.63 | -0.09 | -0.98% |
| Direxion Daily AMZN Bear 1X ETF (AMZD) | |||